Received Dec 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received the 1st Shingrix never got 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose 4.5 years ago, on 01-JUN-2021). The patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: received the 1st Shingrix never got 2nd dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 29-DEC-2025 The reporter needs to know if patient could just receive the 2nd or need to restart the series. The vaccine administration facility is the same as primary reporter. This case US2025167211 was linked with case reported by same reporter.; Sender's Comments: US-GSK-US2025167211:Same reporter/Different patient